Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial

Han Chong Toh, M-H Yang, Wang Hm, Chia Hsieh, I. Chitapanarux, Kean Fatt Ho, R-L. Hong, M-K. Ang, A.D. Colevas, E. Sirachainan, C. Lertbutsayanukul, Gwo Fuang Ho, Eric Nadler, Alain P. Algazi, Premal Lulla, Lori J. Wirth, K. Wirasorn, Yi‐Chun Liu, S.F. Ang, S.H.J. Low, Lye Mun Tho, Harissa Husainy Hasbullah, Malcolm K. Brenner, W.-W. Wang, Whee-Sze Ong, Sze Huey Tan, Ivan D. Horak, Chunming Ding, Aung Myo, Jens Samol